Publication Date: 2022-12-12
Practice Area: Food and Drug Act | Securities Litigation
Industry: Pharmaceuticals
Court: Appellate Division, First Department
Judge: Justice Presiding Judith Gische
Attorneys: For plaintiff: For Appellant: Michael J. Wernke and Jeremy A. Lieberman of counsel, Pomerantz LLP, New York, Patrick V. Dahlstrom of counse, Peretz Bronstein of counsel, Bronstein, Gewirtz & Grossman, LLC, New York.
for defendant: For Genfit, S.A., Jean-Francois Mouney, Nathalie Huitorel, Xavier Guille Des Buttes, Catherine LaRue, Anne-HÉlÈne Monsellato, FrÉdÉric Desdouits, Florence SÉjournÉ and Philippe Moons, Respondents: Sarah M. Lightdale, Aric H. Wu and Christopher L. Martin, Jr. of counsel, Cooley LLP, New York.
For SVB Leerink LLC, Barclays Capital Inc., H.C. Wainwright & Co., Roth Capital Partners, LLC, Bryan, Garnier & Co. Limited and Natixis, Respondents: Susan L. Saltzstein, Scott D. Musoff and Maria da Silva of counsel, Skadden, Arps, Slate, Meagher & Flom LLP, New York,
Case Number: 657123/20
Securities Misstatement Suit Dismissed; Drug Maker Did Not Falsify, Conceal Trial Data